AI Science Tracker
EN

Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network.

Affiliation not stated in the reviewed material · 28 Sep 2021 · biology

Discovery

Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: RF/ANN gene signature for primary infliximab nonresponse in UC; GSE16879 and GSE12251 training (n=46 total), independent GSE23597 validation (n=28), response assessed at 4/8 weeks using mucosal healing definition.

Technology: Learned gene signature predicts a specific treatment-response endpoint in independent public data; retrospective and small-cohort.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Learned gene signature predicts a specific treatment-response endpoint in independent public data; retrospective and small-cohort.
Limitation / still unknown
The gene signature was trained on 46 cases and checked in 28 independent cases; these small transcriptomic cohorts do not establish causal mechanisms or clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.678424/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.